Product Liability
Did Boston Scientific lose $74M mesh trial over an email? | MassDevice.com On Call
MASSDEVICE ON CALL — Medtech titan Boston Scientific‘s (NYSE:BSX) logged a major loss after winning a few rounds in the ongoing lawsuits over its vaginal sling implants, and the deciding factor may have been the revelation of an internal company email.